AbbVie Inc (ABBV) Holdings Cut by South Street Advisors LLC

Cornelia Mascio
Febbraio 21, 2018

National Planning Corp decreased its stake in Abbvie Inc (ABBV) by 9.02% based on its latest 2017Q3 regulatory filing with the SEC.

Shares of AbbVie Inc (NYSE:ABBV) opened at $117.98 on Wednesday.

Sumitomo Mitsui Asset Management Company Ltd, which manages about $6.41 billion US Long portfolio, decreased its stake in Kimco Rlty Corp (NYSE:KIM) by 114,574 shares to 651,744 shares, valued at $12.74 million in 2017Q3, according to the filing. It worsened, as 55 investors sold AbbVie Inc. shares while 640 reduced holdings.

The stock increased 3.52% or $0.86 during the last trading session, reaching $25.26. About 1.04 million shares traded.

AbbVie Inc. (NYSE:ABBV) received a Buy rating from 3 analysts. It has underperformed by 6.07% the S&P500. The company reported $1.48 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.44 by $0.04. (NYSE:ABBV). Opus Invest holds 1.32% or 81,700 shares. Van Eck Assocs Corporation reported 0.08% in AbbVie Inc. Following the completion of the transaction, the chairman now owns 492,030 shares of the company's stock, valued at approximately $46,255,740.30. The New York-based Citigroup Incorporated has invested 0% in Hanesbrands Inc. (NYSE:ABBV). 141,637 were reported by Fred Alger Management.

Segment Wealth Management Ltd Llc has invested 0.19% of its portfolio in AbbVie Inc. Principal stated it has 375,477 shares or 0.03% of all its holdings. Oregon Employees Retirement Fund has 86,997 shares for 0.22% of their portfolio. The institutional investor held 133,050 shares of the oil refining and marketing company at the end of 2017Q3, valued at $3.27M, up from 105,630 at the end of the previous reported quarter. (NYSE:ABBV). Park Oh invested in 290,783 shares or 1.48% of the stock. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Insider ownership increased by a total of 154829 shares, which suggests that ABBV's key executives are feeling more optimistic about the outlook for the stock. Piper Jaffray maintained AbbVie Inc. The lower end of the projection is $1.72 per share, while the higher end is $1.81 per share. ABBV's profit will be $2.83 billion for 16.91 P/E if the $1.78 EPS becomes a reality. AbbVie's revenue for the quarter was up 13.9% on a year-over-year basis. analysts expect that AbbVie Inc will post 7.46 EPS for the current year. (NYSE:ABBV). Accredited Invsts Inc invested in 2,873 shares. Therefore 100% are positive. The rating was upgraded by Citigroup to "Buy" on Tuesday, February 23. BMO Capital Markets maintained it with "Hold" rating and $6600 target in Wednesday, June 7 report. Private Capital Advisors Inc. now owns 41,620 shares of the company's stock worth $3,018,000 after buying an additional 145 shares during the period. As per Wednesday, April 6, the company rating was initiated by Societe Generale. The firm has "Overweight" rating given on Tuesday, September 8 by JP Morgan. On Friday, October 13 the stock rating was maintained by UBS with "Neutral". BMO Capital Markets has "Hold" rating and $6600 target. Leerink Swann downgraded AbbVie from an "outperform" rating to a "market perform" rating and set a $127.00 target price for the a research report on Monday, January 29th. The rating was maintained by Barclays Capital with "Equal-Weight" on Friday, October 13. Savant Capital LLC now owns 61,132 shares of the company's stock valued at $4,433,000 after purchasing an additional 793 shares in the last quarter. Ffcm LLC grew its holdings in AbbVie by 167.2% in the 2nd quarter.

The data from the past twelve months tells a different story: insiders executed 21 buys and 37 sells, and ownership decreased by a net of 1.1 million shares. The shares were sold at an average price of $96.71, for a total value of $14,072,272.10.

More notable recent AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26. The original version of this article can be viewed at About 8.75 million shares traded or 45.70% up from the average. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Therefore 71% are positive.

Several research analysts have recently issued reports on the stock. Oppenheimer maintained, Inc. The stock of Xencor, Inc. The firm has "Hold" rating given on Friday, August 21 by Vetr. As per Thursday, December 21, the company rating was maintained by Jefferies. (NASDAQ:AMZN) rating on Tuesday, June 6. The rating was maintained by Stifel Nicolaus with "Buy" on Thursday, February 25. The firm earned "Market Perform" rating on Thursday, November 17 by Telsey Advisory.

Investors sentiment decreased to 0.9 in 2017 Q3. Its down 0.10, from 1.36 in 2017Q2. It dived, as 43 investors sold HBI shares while 189 reduced holdings. 279.77 million shares or 1.91% less from 285.20 million shares in 2017Q2 were reported. Invesco Limited stated it has 0% in Xencor, Inc. (NASDAQ:AMZN) or 844,380 shares. Ffcm LLC now owns 1,539 shares of the company's stock valued at $111,000 after purchasing an additional 963 shares in the last quarter. Shoker Invest Counsel has 0.24% invested in, Inc. (NASDAQ:AMZN). 5,423 are held by Oakwood Capital Management Limited Liability Ca. Manufacturers Life Ins The owns 1.18 million shares. Family Firm Inc holds 4,662 shares or 0.17% of its portfolio.

LoweÂ's Companies, Inc. operates as a home improvement firm in the United States, Canada, and Mexico. Doheny Asset Mgmt Ca owns 133,050 shares. 11,551 are held by Montrusco Bolton Investments Incorporated. Uss Management Ltd stated it has 903,800 shares. 12,768 were accumulated by 1832 Asset Mngmt L P.

Since August 28, 2017, it had 0 insider purchases, and 2 sales for $1.32 million activity.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE